NBM-BMX softgel capsules

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameNBM-BMX softgel capsules
Drug Alias NameNBM-BMX oral softgel capsulesNBM-BMX
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 8 inhibitors
TargetsHistone deacetylase 8
Therapy Area/IndicationsUveal melanomaBrain NeoplasmsEye Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNaturewise Biotech & Medicals
China Registration ClassN/A

Develop Information

Active CompaniesNovelwise Pharmaceutical Corp
Inactive CompaniesNaturewise Biotech & Medicals Co
Active IndicationsUveal melanomaBrain NeoplasmsEye Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A